• Tue, March 17, 2020

by: WOPRAI

Stephen Willey Maintained (SPRO) at Strong Buy with Decreased Target to $21 on, Mar 17th, 2020

by: WOPRAI

George Mihalos Upgraded (SQ) to Buy and Held Target at $70 on, Mar 17th, 2020

by: WOPRAI

Brett Huff Maintained (SQ) at Buy with Decreased Target to $59 on, Mar 17th, 2020

by: WOPRAI

Alex Rygiel Maintained (TMHC) at Strong Buy with Decreased Target to $23 on, Mar 17th, 2020

by: WOPRAI

Courtney Yakavonis Maintained (TKR) at Hold with Decreased Target to $48 on, Mar 17th, 2020

by: WOPRAI

Simeon Gutman Maintained (TGT) at Hold with Decreased Target to $110 on, Mar 17th, 2020

by: WOPRAI

Alex Rygiel Maintained (TPC) at Strong Buy with Decreased Target to $17 on, Mar 17th, 2020

by: WOPRAI

Alex Rygiel Downgraded (TPH) to Hold and Decreased Target to $11 on, Mar 17th, 2020

by: WOPRAI

Simeon Gutman Maintained (ULTA) at Hold with Decreased Target to $250 on, Mar 17th, 2020

by: WOPRAI

Nigel Dally Maintained (UNM) at Hold with Decreased Target to $18 on, Mar 17th, 2020

by: WOPRAI

Joshua Pokrzywinski Maintained (WMS) at Hold with Decreased Target to $39 on, Mar 17th, 2020

by: WOPRAI

Rupesh Parikh Upgraded (WMT) to Buy and Held Target at $42 on, Mar 17th, 2020

by: WOPRAI

Simeon Gutman Maintained (WSM) at Sell with Decreased Target to $23 on, Mar 17th, 2020

by: WOPRAI

Mark Zgutowicz Upgraded (WIX) to Hold and Held Target at $102 on, Mar 17th, 2020

by: WOPRAI

Selman Akyol Maintained (WMB) at Strong Buy with Decreased Target to $25 on, Mar 17th, 2020

by: WOPRAI

Celine Pannuti Maintained (CCEP) at Buy with Decreased Target to $45 on, Mar 17th, 2020

by: WOPRAI

Alex Rygiel Maintained (CCS) at Strong Buy with Decreased Target to $28 on, Mar 17th, 2020

by: WOPRAI

Ken Zerbe Maintained (CFR) at Sell with Decreased Target to $72 on, Mar 17th, 2020

by: WOPRAI

Courtney Yakavonis Maintained (TEX) at Hold with Decreased Target to $22 on, Mar 17th, 2020

by: WOPRAI

David George Upgraded (TFC) to Buy and Held Target at $56 on, Mar 17th, 2020

by: WOPRAI

Alex Rygiel Downgraded (TGLS) to Hold and Decreased Target to $4.5 on, Mar 17th, 2020

by: WOPRAI

Josh Vogel Upgraded (TBI) to Strong Buy on, Mar 17th, 2020

by: WOPRAI

Alex Rygiel Maintained (BXC) at Strong Buy with Decreased Target to $9 on, Mar 17th, 2020

by: WOPRAI

George Farmer Upgraded (BPMC) to Buy and Increased Target to $89 on, Mar 17th, 2020

by: WOPRAI

Konstantinos Aprilakis Upgraded (BPMC) to Strong Buy and Held Target at $70 on, Mar 17th, 2020

by: WOPRAI

Ken Zerbe Maintained (BOKF) at Hold with Decreased Target to $75 on, Mar 17th, 2020

by: WOPRAI

John Freeman Downgraded (YPF) to Buy on, Mar 17th, 2020

by: WOPRAI

Ariel Rosa Upgraded (XPO) to Strong Buy on, Mar 17th, 2020

by: WOPRAI

Tycho Peterson Maintained (XRAY) at Hold with Decreased Target to $45 on, Mar 17th, 2020

by: WOPRAI

Jeff Van Sinderen Maintained (XPEL) at Strong Buy with Decreased Target to $18 on, Mar 17th, 2020

by: WOPRAI

Joshua Pokrzywinski Maintained (WSO) at Hold with Decreased Target to $147 on, Mar 17th, 2020

by: WOPRAI

Tom Curran Maintained (WTTR) at Strong Buy with Decreased Target to $8 on, Mar 17th, 2020

by: WOPRAI

Michael Pachter Maintained (AMZN) at Buy and Held Target at $116 on, Mar 17th, 2020

by: WOPRAI

Nigel Dally Maintained (AMP) at Hold with Decreased Target to $127 on, Mar 17th, 2020

by: WOPRAI

John Freeman Downgraded (APA) to Hold on, Mar 17th, 2020

by: WOPRAI

Phil Stefano Maintained (AON) at Hold with Decreased Target to $180 on, Mar 17th, 2020

by: WOPRAI

Meyer Shields Upgraded (AJG) to Buy on, Mar 17th, 2020

by: WOPRAI

Phil Stefano Maintained (AJG) at Hold with Decreased Target to $90 on, Mar 17th, 2020

by: WOPRAI

Courtney Yakavonis Maintained (AGCO) at Hold with Decreased Target to $75 on, Mar 17th, 2020

by: WOPRAI

Ken Zerbe Maintained (CBSH) at Sell with Decreased Target to $42 on, Mar 17th, 2020

by: WOPRAI

Marvin Fong Upgraded (CARG) to Strong Buy on, Mar 17th, 2020

by: WOPRAI

Courtney Yakavonis Maintained (CAT) at Hold with Decreased Target to $115 on, Mar 17th, 2020

by: WOPRAI

Ken Zerbe Maintained (CADE) at Hold with Decreased Target to $13 on, Mar 17th, 2020

by: WOPRAI

Ben Bienvenu Upgraded (CALM) to Buy and Increased Target to $47 on, Mar 17th, 2020

by: WOPRAI

Richard Valera Initiated (ZM) at Strong Buy and Held Target at $140 on, Mar 17th, 2020

by: WOPRAI

Ken Zerbe Maintained (ZION) at Hold with Decreased Target to $40 on, Mar 17th, 2020

by: WOPRAI

Alex Rygiel Maintained (BBCP) at Strong Buy with Decreased Target to $5 on, Mar 17th, 2020

by: WOPRAI

Benjamin Swinburne Maintained (BATRK) at Hold with Decreased Target to $19 on, Mar 17th, 2020

Konstantinos Aprilakis Upgraded (BPMC) to Strong Buy and Held Target at $70 on, Mar 17th, 2020

Konstantinos Aprilakis of Deutsche Bank, Upgraded "Blueprint Medicines Corporation" (BPMC) to Strong Buy and Held Target at $70 on, Mar 17th, 2020.

Konstantinos has made no other calls on BPMC in the last 4 months.



There is 1 other peer that has a rating on BPMC. Out of the 1 peers that are also analyzing BPMC, 0 agree with Konstantinos's Rating of Hold.



This is the rating of the analyst that currently disagrees with Konstantinos

  • Andrew Berens of "Morgan Stanley" Maintained at Buy with Decreased Target to $103 on, Tuesday, February 18th, 2020